Menu Search
Equities

Shanghai MicroPort Endovascular MedTech Group Co Ltd

688016:SHH

Shanghai MicroPort Endovascular MedTech Group Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)80.71
  • Today's Change-29.73 / -26.92%
  • Shares traded1.39m
  • 1 Year change-41.62%
  • Beta1.1723
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy2
Outperform6
Hold1
Sell0
Strong Sell0

Share price forecast in CNY

The 3 analysts offering 12 month price targets for Shanghai MicroPort Edvcl MdTch Grp CoLtd have a median target of 140.00, with a high estimate of 185.72 and a low estimate of 120.00. The median estimate represents a 33.08% increase from the last price of 105.20.
High76.5%185.72
Med33.1%140.00
Low14.1%120.00

Dividends in CNY

In 2023, Shanghai MicroPort Endovascular MedTech Group Co Ltd reported a dividend of 2.01 CNY, which represents a 30.43% increase over last year. The 6 analysts covering the company expect dividends of 2.46 CNY for the upcoming fiscal year, an increase of 22.13%.
Div growth (TTM)30.43%
More ▼

Earnings history & estimates in CNY

On Oct 29, 2024, Shanghai MicroPort Edvcl MdTch Grp CoLtd reported 3rd quarter 2024 earnings of 1.22 per share.
The next earnings announcement is expected on Feb 27, 2025.
Average growth rate+9.56%
Shanghai MicroPort Edvcl MdTch Grp CoLtd reported annual 2023 earnings of 4.57 per share on Feb 23, 2024.
Average growth rate+31.65%
More ▼

Revenue history & estimates in CNY

Shanghai MicroPort Endovascular MedTech Co., Ltd. had 3rd quarter 2024 revenues of 182.39m. This missed the 376.04m estimate of the one analyst following the company. This was 36.14% below the prior year's 3rd quarter results.
Average growth rate-1.46%
Shanghai MicroPort Endovascular MedTech Co., Ltd. had revenues for the full year 2023 of 1.19bn. This was 32.43% above the prior year's results.
Average growth rate+37.47%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.